clinical trial · NCT07038473
Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)
Type 1 DiabetesInvestigational Procedure
brief summary
The aim of this research is to identify pre-symptomatic Type 1 Diabetes (T1D) in young children and adolescents who have first degree relatives with T1D. This protocol has been developed to address the growing need for standardized T1D screening, monitoring, and data collection in alignment with international recommendations. The study's estimated duration is 13 months and will consist of two visits: Visit 1 (screening visit) and Visit 2 (confirmatory visit).
started
Dec 17, 2025
primary completion
Dec 25, 2026
completion
Dec 25, 2026
last updated
Aug 19, 2026
official title
Islet Autoantibody Early Detection in At-risk Children/Adolescents to Predict Type 1 Diabetes: a Cohort Study in Gulf Countries
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol